Stuart Isaacson

7.5k citations
185 papers · 5.5k · 5 hit papers · h-index 39

Impact in

  • Neurology top 0.2%
    • Parkinson's Disease Mechanisms and Treatments
    • Neurological disorders and treatments
    • Botulinum Toxin and Related Neurological Disorders
    • Dementia and Cognitive Impairment Research
    • Schizophrenia research and treatment

Papers in

    • Parkinson's Disease Mechanisms and Treatments 138
    • Neurological disorders and treatments 16
    • Botulinum Toxin and Related Neurological Disorders 12
    • Schizophrenia research and treatment 11
    • Dementia and Cognitive Impairment Research 3

Stuart Isaacson

176 papers receiving 5.3k citations

Stuart Isaacson's Hit Papers

Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial 2024 · 59 citations
590+4+8Years since publication100200300400500

Peers

Stuart Isaacson
Comparison fields: 5 of 112
  • Neurology 3.7k
  • Psychiatry and Mental health 473
  • Physical Therapy, Sports Therapy and Rehabilitation 110
  • Neurology 125
  • Physiology 392
Replace Mark Lew with:
Mark Lew United States
Florian Krismer Austria
Joong‐Seok Kim South Korea
Gennaro Pagano United Kingdom
Lonneke M.L. de Lau Netherlands
Christine Brefel‐Courbon France
C H Hawkes United Kingdom
Aristide Merola United States
Sun Ju Chung South Korea
Paolo Del Dotto Italy
Stuart Isaacson relative to Mark Lew United States Mark Lew's profile →
Citations per field
00.5×1.5×2×2.4×
Mark Lew · 1×
Citations per year

Countries citing papers authored by Stuart Isaacson

Since Specialization
Citations

This map shows the geographic impact of Stuart Isaacson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Isaacson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Isaacson more than expected).

Fields of papers citing papers by Stuart Isaacson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Isaacson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Isaacson. The network helps show where Stuart Isaacson may publish in the future.

Co-authors

The 25 scholars most cited alongside Stuart Isaacson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stuart Isaacson Line = papers co-authored together Stuart Isaacson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
2013589
2
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension
Hit paper breakdown →
2017333
3 2018258
4 2014215
5 2017143
6 2015138
7 2014130
8
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
Hit paper breakdown →
2024130
9 2015126
10 2016125
11 2019121
12 2017114
13 2019106
14 2019105
15 2019102
16 201795
17 200893
18 200889
19 201487
20 201786

About Stuart Isaacson

Stuart Isaacson is a scholar working on Neurology, Psychiatry and Mental health, Physiology, Surgery and Physical Therapy, Sports Therapy and Rehabilitation, having authored 185 papers that have together received 5.5k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (138 papers), Neurological disorders and treatments (16 papers), Botulinum Toxin and Related Neurological Disorders (12 papers), Schizophrenia research and treatment (11 papers), Cardiovascular Syncope and Autonomic Disorders (10 papers), Lysosomal Storage Disorders Research (5 papers), Alzheimer's disease research and treatments (3 papers) and Dementia and Cognitive Impairment Research (3 papers). The work is most often cited by research in Neurology (3.7k citations), Psychiatry and Mental health (473 citations), Physical Therapy, Sports Therapy and Rehabilitation (110 citations), Neurology (125 citations) and Physiology (392 citations). Stuart Isaacson has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Robert A. Hauser, Rajesh Pahwa, Clive G. Ballard, Roger Mills, Hilde Williams, Anne Corbett, Kathy Chi‐Burris, Jeffrey L. Cummings, Rohit Dhall and Mark Lew. Their work appears in journals such as Neurology, Parkinsonism & Related Disorders, Journal of Parkinson s Disease, Movement Disorders and JAMA Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact